Rigel Pharmaceutical Inc. buy klostergang
Start price
18.04.17
/
50%
€2.93
Target price
10.05.17
€3.61
Performance (%)
-20.62%
End price
10.05.17
€2.33
Summary
This prediction ended on 10.05.17 with a price of €2.33. The prediction for Rigel Pharmaceutical Inc. disappointed with a performance of -20.62%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by klostergang for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
klostergang stimmt der Buy-Einschätzung von tamam zu
klostergang stimmt am 18.04.2017 der Buy-Einschätzung von tamam mit dem Kursziel 4$ zu.Überschrift: Rigel Pharmaceuticals (NASDAQ:RIGL) submits a New Drug Application
(Vom Mitglied beendet)
Stopped prediction by klostergang for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.32
14.07.20
14.07.20
€1.00
04.11.21
04.11.21
4.88%
17.06.21
17.06.21
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.79
23.01.19
23.01.19
€5.05
14.07.20
14.07.20
84.97%
14.07.20
14.07.20


